Journal of General Virology, Vol 80, 225-236, Copyright © 1999 by Society for General Microbiology

ARTICLES

Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions

NA Jackson, M Levi, B Wahren and NJ Dimmock
Department of Biological Sciences, University of Warwick, Coventry, UK.

Only two virus-neutralizing peptide microantibodies (MicroAbs) have been described and little is known about their mode of action. This report concerns a 17 amino acid cyclized MicroAb, derived from the third complementarity-determining region of the heavy chain of MAb F58 (IgG1), that recognizes the same minimum epitope in the V3 loop of the gp120 envelope protein of human immunodeficiency virus type 1 (HIV-1) as the MAb. The MicroAb was able to bind to and neutralize free virus particles. It was up to 5-fold more efficient in mass terms than F58 IgG and its neutralization rate on a molar basis was only 32-fold lower. The mechanism of neutralization of the MicroAb was also investigated. A high level of neutralization (99%) occurred without any significant decrease in attachment of virus to target C8166 cells. Neutralized virus attached to CD4, the HIV-1 primary receptor. Fusion of virions to cells was partially inhibited by the MicroAb, whereas F58 IgG has been shown to inhibit fusion significantly. Thus, neutralization by the MicroAb appears to be mediated, at least in part, by inhibition of fusion. Control peptides, in which the tyrosine at position 5 or 6 was deleted or changed to phenylalanine, showed no antiviral activity, attesting to the specificity of interaction of the MicroAb with the virion. It therefore appears that the MicroAb acts like an immunoglobulin. The data also show that the MicroAb/MAb F58 epitope on the V3 loop is not involved in attachment of virus to CD4 but is required for subsequent events in early infection.

This article has been cited by other articles:

				C. J. Heap, Y. Wang, T. J. T. Pinheiro, S. A. Reading, K. R. Jennings, and N. J. Dimmock Analysis of a 17-amino acid residue, virus-neutralizing microantibody J. Gen. Virol., June 1, 2005; 86(6): 1791 - 1800. [Abstract] [Full Text] [PDF]

				C. J. Heap, S. A. Reading, and N. J. Dimmock An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion J. Gen. Virol., May 1, 2005; 86(5): 1499 - 1507. [Abstract] [Full Text] [PDF]

				L. Cheung, L. McLain, M. J. Hollier, S. A. Reading, and N. J. Dimmock Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion J. Gen. Virol., January 1, 2005; 86(1): 131 - 138. [Abstract] [Full Text] [PDF]

				S. M. Cleveland, L. McLain, L. Cheung, T. D. Jones, M. Hollier, and N. J. Dimmock A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion J. Gen. Virol., March 1, 2003; 84(3): 591 - 602. [Abstract] [Full Text] [PDF]

				M. J. Edwards and N. J. Dimmock Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event J. Virol., November 1, 2001; 75(21): 10208 - 10218. [Abstract] [Full Text] [PDF]

				S. M. Cleveland, T. D. Jones, and N. J. Dimmock Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1 J. Gen. Virol., May 1, 2000; 81(5): 1251 - 1260. [Abstract] [Full Text]